Look at the tape before you read the tweet.
On Thursday, September 24, STRF closed at $103.28 on 20,313 shares. STRC closed at $98.28 on 1,023,834 shares. STRK closed at $73.59 on 69,162 shares. STRD closed at $72.10 on 93,762 shares. Those are the last uncontaminated baselines we have, because the following day the @saylor account announced that Strategy wants dividends on all four preferred series to accrue every calendar day — weekends and holidays included — and to settle on the next business day.
Read the announcement closely and you find what is missing: no daily record dates, no effective date, no series-by-series approval path. Strategy's August 31 declaration still governs, and it still pays STRF, STRK and STRD quarterly and STRC twice monthly. The proposal changes a timetable on paper. It has not yet changed a single cash flow.
The code does not lie, only the narrative. So let's audit the code.
The Product Is the Capital Structure
Strategy is not, functionally, a software company. The legacy reporting line is a wrapper around a Bitcoin treasury and, more importantly, around a financing machine whose actual output is securities.
Four preferred series sit inside that machine. Each carries its own coupon, its own cumulative or noncumulative treatment, its own claim position, and its own trading character. They are not interchangeable, and the September 25 announcement handled them as though they were.
State of the stack at the September 24 close, with rates and rights drawn from Strategy's filings:
| Series | Payment cadence | Annual rate | Sept. 24 close | Sept. 24 volume | | --- | --- | --- | --- | --- | | STRF | Quarterly | 10%; cumulative | $103.28 | 20,313 shares | | STRC | Twice monthly | 12% at the latest declaration; variable and cumulative | $98.28 | 1,023,834 shares | | STRK | Quarterly | 8%; cumulative | $73.59 | 69,162 shares | | STRD | Quarterly | 10%; noncumulative | $72.10 | 93,762 shares |
Two observations land before any analysis. The volume column is not remotely uniform — STRC traded roughly fifty times STRF's volume on the same session. Whales do not whisper; they shake the ledger, and the ledger shows where the size lives.
The price column is not uniform either, and it splits along a line that has nothing to do with settlement frequency.
The August 31 declaration remains the live document. Holders of record on September 15 are due $2.50 per STRF share, $2.00 per STRK share and $2.50 per STRD share on September 30, plus $0.50 per STRC share. A second $0.50 STRC payment lands October 15 for holders of record on September 30. Each STRC payment annualizes at 12%. None of those dates has been replaced.
That is context. Now the part that carries information.
Accrual Is Not Obligation
The most misread word in the announcement is 'accrue.'
Accrual is an accounting convention. Obligation is a legal claim. The post describes the former and lets readers supply the latter, and that gap is where retail capital usually takes damage.
Strategy's preferred disclosures are explicit that payments across all four series remain subject to board declaration and legally available funds. A daily accrual schedule does not create a daily obligation to pay. It creates a daily arithmetic record of what would be owed if the board declares and if the money exists. If the board does not declare, the accrual is bookkeeping, not entitlement.
This is not a technicality. It is the entire architecture of preferred equity. A preferred share is a contract, and the contract's value lives in what it says about the periods when the issuer stops paying — or does not.
I built my working method during the 2017 ICO cycle, auditing fifteen whitepapers line by line and flagging fraudulent tokenomics in three of them before their public launches. The pattern is stable across cycles. The documents that impress people most are the ones with the most elaborate schedules and charts. The ones that protect people are the ones with the clearest claim on assets. A faster calendar is not a stronger claim. Those are two different instruments, and only one of them is enforceable.
The $100 Line Is Not a Peg
There is a second source of confusion running through this story, and it is the number 100.
Traders talk about the $100 level on STRF and STRC as though it were a redemption anchor. It is a comparison point. In its June 30 filing, Strategy listed $0.001 legal par for these securities and no $100 stated amount for STRK, even though it reported a $100 liquidation preference for STRK at that date. The other series carry their own preferred terms.
That means the distance between $73.59 and $100 on STRK is not a 26% discount to redemption. It is a spread between a trading price and a reference figure that has no legal force at that number. Pegs break, principles remain, portfolios vanish — but here there is no peg to break, only a convention people keep quoting.
I make this point because mispricing a reference line is how holders end up with the wrong expectations. If you believe STRK is 26% cheap to a $100 redemption, daily dividends look like a catalyst that could close the gap. If you understand that $100 is a convention, daily dividends look like what they are: a scheduling change on a security whose discount comes from an 8% coupon in a 10-to-12% market.
The Only Line That Matters
STRF and STRD share a stated annual rate. Ten percent. Both pay quarterly. On September 24 they closed 31.18 points apart: $103.28 against $72.10.
Cadence cannot explain that gap. Coupon cannot explain it either. The difference is a single term: STRF's dividends are cumulative, STRD's are not.
Cumulative means an unpaid amount persists as an arrears claim. Noncumulative means an omitted regular dividend simply disappears; it does not become a debt the issuer owes later.
The market has priced that one word at roughly $31 per $100 of par, which against a $10 annual dividend is about three years of distributions. The market is not confused about payment frequency. It is pricing claim quality, and it is pricing it hard.
Set that against the proposal. If STRD moves to daily accrual, holders receive cash sooner in periods when the board declares. They gain precisely nothing in periods when it does not. The structural discount on STRD is a noncumulative discount, and it will persist until the terms change — not until the calendar does.
The 2022 Terra collapse taught the same lesson in a different form. Holders held positions they believed were anchor claims, and the claims turned out to be contingent on an issuer-level mechanism that failed. The question is never how often you are paid. It is who owes you, on what seniority, and under what conditions.
STRK shows the mirror image. It is cumulative, which is genuine protection, but it carries the lowest coupon in the stack at 8%. In a market where the newest series pays 12%, an 8% perpetual does not trade at par, and it does not trade at par because of settlement speed. It trades at $73.59 because a holder can source roughly 12% of yield elsewhere in the same capital structure. You cannot schedule your way to par.
What 45 Days of Float Is Actually Worth
Strip the narrative and the proposal is a present-value transfer of about half a quarter's dividend, from Strategy to preferred holders.
Under a quarterly schedule, each installment arrives at period end. Under a daily schedule, the same annual amount arrives spread across the period, so the average dollar lands roughly 45 days earlier. The holder reinvests that float earlier; the issuer gives it up.
Quantify it. Take $100 of par, an annual dividend D, and an opportunity rate r. The timing benefit is approximately D × r × (45/365). Run it at two defensible rates — a 5% money-market reinvestment assumption, and the instrument's own coupon as a discount rate:
| Series | Annual rate | Daily accrual per $100 par | PV gain at 5% | PV gain at coupon | | --- | --- | --- | --- | --- | | STRF | 10% | $0.0274 | ~6 bps | ~12 bps | | STRC | 12% | $0.0329 | ~7 bps | ~18 bps | | STRK | 8% | $0.0219 | ~5 bps | ~8 bps | | STRD | 10% | $0.0274 | ~6 bps | ~12 bps |
The entire timing benefit is worth single-digit to high-teens basis points of par per year, before tax and administrative friction.
Put that beside the printed prices. STRF sits at $103.28 against a notional 100 — a 328 basis point premium — for reasons unrelated to settlement speed. If daily accrual were the driver the announcement implies, the deepest-discount series should be the natural beneficiaries, since they have the most room to re-rate. But the deep-discount series are discounted for reasons the calendar does not touch.
During the 2020 DeFi Summer I tracked $2.4 billion of Uniswap liquidity flows and built a dashboard comparing advertised APY against realized volume. It showed that roughly 40% of the highest-yield pools were unsustainable. The lesson was not that yield was false. It was that yield without claim quality is a marketing number. The same discipline applies here: a cadence benefit under 20 basis points is not a reason to own anything.
The June 8 Precedent Cuts Both Ways
The cleanest evidence in this file is not in the September 25 announcement. It is in June.
On June 8, majorities of Strategy's common and STRC holders approved moving STRC from monthly to twice-monthly record and payment dates. The June 30 filing states the change took effect that day without increasing the company's dividend obligation.
Useful precedent — it proves Strategy can compress a distribution calendar without re-pricing the security, and that holders will accept a faster cadence at identical economics. If the company wants to argue that daily accrual across four series is an administrative adjustment rather than an economic one, June 8 is the exhibit.
Limiting precedent — it does not answer the question that governs this proposal. What approvals does a daily cadence require for each series? STRC's change required a holder vote because it amended STRC's terms. The September 25 post does not say whether STRF, STRK and STRD would each need their own consent solicitation, whether a single omnibus amendment covers all four, or whether the change is being treated as a payment-mechanics adjustment within existing authority.
Those are not small details. They set the timeline, the cost, and whether the proposal survives contact with the documents. Trace the wallet, ignore the tweet. The announcement is a post. The amendment is a filing. Only one of them can be relied on.
The Reserve, the Buyback, and the Question Nobody Asked
Strategy's September 21 cash update is the most under-read document in this story.
As of September 20, the USD Reserve earmarked for preferred dividends and debt interest stood at $5.04 billion. A separate $1.05 billion of USD Cash was available for broader treasury uses. In the prior week, $57.4 million of reserve money paid preferred dividends and interest. Strategy used USD Cash to repurchase $174 million of STRC and to buy 950 Bitcoin for $75.7 million. It reported no at-the-market share sales that week, and it disclosed $875.1 million of preferred-share repurchase authority remaining.
The buyback is easy to misread, so read it precisely. Repurchasing STRC in the secondary market supports the price of existing STRC shares. It is not new financing from investors. No new capital entered the structure that week. Capital left it.
Which surfaces the question the daily dividend proposal is actually answering: Strategy needs demand for future preferred issuance, and right now it has none to show.
If daily dividends make the preferreds more attractive, sustained buying could firm trading prices, and firmer prices could make a new preferred offering executable at a better cost. That chain has three links, and each is conditional. The September 24 prices and volumes cannot reflect a September 25 proposal. They cannot reflect proceeds from an offering not yet priced. They are a baseline, and a baseline is not evidence.
My 2025 compliance work mapping on-chain data points to institutional requirements made one thing clear: institutional allocators do not buy cadence. They buy claim seniority, disclosure quality, and an auditable payment history. Cadence is a tiebreaker at best, and it is a tiebreaker applied after the coupon and the claim have already been evaluated.
Pre-mortem, then. Assume it is September 2026 and the daily schedule has run for nine months. What does failure look like? The discounts on STRK and STRD persist, because coupon and cumulative status were always the binding constraints. STRC volume stays concentrated, because that is where the float is. Administrative cost per distribution rises faster than the perceived benefit, since the company is now processing fractions of a cent per share per day across millions of shares. And no new preferred series prices at a tighter spread than the last one. In that world, the daily schedule was a cost with a marketing offset, and nothing more.
The success case is narrower and specific: a new series is issued after the change takes effect and clears at a tighter spread than pre-change comparables. That is the number to watch. Everything before it is commentary.
RISK ALERT — Three unresolved items that make this proposal non-actionable as written 1. No effective date, no daily record-date convention, and no series-by-series approval path have been disclosed. 2. Daily accrual does not create a daily obligation. All four series remain subject to board declaration and legally available funds. 3. STRD remains noncumulative. An omitted regular dividend is not recoverable as arrears, regardless of how the calendar is structured.
The Contrarian Read
The consensus frame is that Strategy is doing something holder-friendly. A more useful frame is that this is a demand-engineering exercise wearing a shareholder-benefit narrative, and the two are not the same thing.
Consider the incentive geometry. A holder of $100 par at a 10% coupon receives $10 a year. Moving that from quarterly to daily changes the present value of those dollars by roughly 6 to 12 basis points. That is inside the ordinary bid-ask spread on most of these series on most days. No rational holder re-allocates capital over 12 basis points. If this is being sold as a holder benefit, the arithmetic does not support the pitch.
What the proposal actually does is attach a fresh, quotable attribute to four securities at a moment when Strategy's preferred complex needs a reason to be discussed. It is a listing-page improvement. It is the capital-markets equivalent of a packaging change: same contents, new claim on the front of the box.
Correlation is not causation, and here the correlation has not even formed. The sequence that matters is amended terms, then approvals, then prices, then sustained trading, then issuance. We are at step zero. Anyone telling you the September 25 post is bullish for STRF, STRC, STRK or STRD is describing a hypothesis, not an observation.
There is a governance angle too. Audits reveal the skeleton, not the soul. The filings tell you what the terms are. They do not tell you what a board will declare in a stressed quarter, and on STRD that distinction is worth $31 per $100 of par.
Takeaway
Watch the amendment, not the announcement. The next signal with real information content is a filing that specifies daily record dates, an effective date, and an approval path for each of the four series — followed by a price reaction that survives more than one session, followed by an actual offering. Until that sequence appears, the daily dividend proposal has moved a timetable and nothing else.